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Liquid chromatographyAbstract A selective chiral ultra fast liquid chromatography (UFLC-DAD) method was developed
and validated to separate and quantify the (d)- and (l)-enantiomers of doxylamine in rat plasma.
After extraction of the plasma samples with acetonitrile, the separation of doxylamine succinate
enantiomers and internal standard (I.S., diphenhydramine hydrochloride) was achieved on a cellu-
lose Tris (4-chloro,3-methylphenylcarbamate) column with a mobile phase of 20 mM ammonium
bicarbonate buffer–acetonitrile (65:35 v/v) with 0.15% diethylamine in the buffer at a ﬂow rate
of 1.0 mL/min. The diode array (DAD) detection wavelength was set at 220 nm. The peaks
obtained were identiﬁed as (d) and (l) by injecting the pure (d) form into the liquid chromatography
and comparing the chromatograms. The effect of column oven temperature on the retention of
doxylamine and mobile phase variables which have an effect on the enantiomers separation like
ionic strength, type and concentration of organic modiﬁer was studied. Linear calibration curves
were obtained over the range of 100–1400 ng/mL in plasma for both enantiomers (R2 > 0.995).
The mean extraction recoveries were 94.5–104.7% of rat plasma. The mean relative standard devi-
ation (RSD%) of accuracy and intra-day and inter-day precision for both enantiomers were 610%.
The method can be further applied to determine the pharmacokinetics of (d)- and (l)-enantiomers in
rat plasma.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Antihistamine drugs can be broadly classiﬁed into H1 receptor
antagonists, H2 receptor antagonists and H3 receptor antago-
nists. H1 receptors present in smooth muscles are blocked by
classical antihistamines. H2 receptors present in the stomach,
stimulate gastric acid secretion. H3 receptors primarily foundin the brain, trigger the release of excitatory neurotransmitters.
H1 receptor antagonists can be classiﬁed into seven groups
based on their chemical structure. Doxylamine succinate
(Fig. 1a) is one of the ﬁrst generation H1 receptor antagonists
of the ethanolamine group.1 Diphenhydramine hydrochloride
(Fig. 1b) is anti-histamine and used as internal standard.
Doxylamine succinate is used as an anti-allergic and it is
also used in the treatment of hay fever. Doxylamine because
of its sedative action acts as a sleeping aid.2 Doxylamine suc-
cinate is a basic drug with the pKa 8.8 and its IUPAC name
is (RS)-N,N-dimethyl-2-(1-phenyl-1-pyridin-2-yl-ethoxy)-etha
namine. It has one chiral carbon center in the phenyl ethoxy
Figure 1 (a) Structure of doxylamine succinate, (b) structure of
diphenhydramine hydrochloride.
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available as the succinate salt. Investigations have shown that
doxylamine was used as a racemic mixture clinically. But
according to the patent published on 25th December 2013,3
(d)-doxylamine is more efﬁcient in resisting allergy and
improving sleep when compared with the racemic form.
Hence there is a need for the separation of enantiomers.
Examination of the literature reveals that few methods like
derivative spectrophotometry,4 FT-IR,5 UV,6 HPLC,7 LC–
MS8,9 have been reported for the quantiﬁcation of racemic
(±) doxylamine in pharmaceutical formulations and in biolog-
ical ﬂuids. Also few methods have been reported for the reso-
lution of doxylamine enantiomers in human plasma by using
capillary electrophoresis10 and high performance liquid chro-
matography.11,12 However the reported methods have their
own drawbacks like individual enantiomers (d)- and (l)-
doxylamine were not identiﬁed, the methods were developed
in the normal phase mode and also the stability of the enan-
tiomers was not determined.
The objective of the present study is to develop a method
for the resolution of enantiomers in a reverse phase mode,
which is more reproducible when compared to the normal
phase, identifying the (d)- and (l)-doxylamine enantiomeric
peaks and also carrying out the full validated bio-analytical
procedure including the stability study for the enantiomers in
rat plasma.
2. Experimental
2.1. Materials and methods
An Analytically pure reference standard of doxylamine succi-
nate was supplied by R L Fine Chem (Bangalore, India),
and was used as such without further puriﬁcation. The chem-
icals like ammonium bicarbonate (HPLC grade, Sigma–
Aldrich, India), acetonitrile (HPLC grade, Merck Specialities
Pvt. Ltd., Mumbai, India), and diethylamine (HPLC grade,
Spectrochem Pvt. Ltd., Mumbai, India) were used in the anal-
ysis. Blank plasma was obtained from JSS Medical College
and Hospital, Mysuru, India.
2.2. Instrumentation
The ultra fast liquid chromatography (UFLC) used to be
of Shimadzu Prominence LC-20AD equipped with a 1260
binary pump VL (35 MPa), Prominence SIL-20ACHT
Autosampler, and Prominence SPD-M20A Diode array
detector. All weighings for analysis were performed on aShimadzu electronic analytical balance AY-220 (Shimadzu).
Mixing was performed on a REMI Cyclomixer followed by
sonication on an ultrasonic bath (Mark ultrasonic sonicator).
Centrifugation was done using REMI cooling centrifuge
model number 412 LAG (REMI instruments division,
Vasai, India). Pipetting was performed by using 20–200 lL
and 500–5000 lL adjustable micropipettes (Phenomenex).
Bio-samples were stored at 80 C in an Ultra low, deep
freezer (REMI). Plasma samples were ﬁltered using 0.45 lm
ﬁlters from Phenomenex. Water used for analysis was pre-
pared from Millipak Express 20 ﬁlter unit. The blank plasma
has been procured in its original form, from the animal house
of JSS College of Pharmacy, Mysuru, India.
2.3. Chromatography conditions
The chromatographic separation of diphenhydramine
hydrochloride (IS) and doxylamine enantiomers was accom-
plished using a 250 · 4.6 mm cellulose Tris (4-chloro,3-methyl
phenylcarbamate) column attached to a pre-column holder
for Cartridge containing cellulose Tris (4-chloro,3-methylphe
nylcarbamate) (4 · 2.0 mm) guard column. The UV wave-
length was set at 220 nm. Chromatography data were col-
lected and compiled by use of LC solutions software. The
mobile phase used was a 65:35 (v/v) mixture of 20 mM
ammonium bicarbonate buffer (pH 6.6) and acetonitrile to
which 0.15% diethylamine was added. The mobile phase
was pumped at a ﬂow rate of 1.0 mL/min.
2.4. Preparation of standard drug solutions
Doxylamine succinate stock solution was prepared by dissolv-
ing 10 mg of pure drug in 100 mL of Milli pore water
(100 lg/mL). The single enantiomer stock solution was pre-
pared by dissolving 10 mg of pure (d)-form of doxylamine in
100 mL of Millipore water (100 lg/mL). Diphenhydramine
hydrochloride (internal standard) stock solution was prepared
by dissolving 10 mg of pure drug in 100 mL of Milli pore water
(100 lg/mL). The solutions were sonicated for 5 min and
allowed to equilibrate at room temperature. The working stan-
dard drug solutions (1–14 lg/mL) were prepared by serial dilu-
tion of the stock drug solution. The working IS solution of
5 lg/mL was prepared by appropriate dilution of the IS stock
solution. All solutions were stored at 2–8 C.
2.5. Preparation of standard plasma samples
Standard plasma samples ranged from 100 to 1400 ng/mL of
the drug with 500 ng/mL of IS prepared by spiking 500 lL
blank rat plasma with appropriate working standards of drug
and IS.
2.6. Preparation of quality control samples
Three quality control (QC) plasma samples at concentrations
of 200, 600, and 1000 ng/mL and one lower limit of quantiﬁca-
tion (LLOQ) sample at a concentration of 100 ng/mL were
prepared by spiking 500 lL blank plasma with appropriate
drug and IS solutions.
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A simple protein precipitation method was followed for the
extraction of doxylamine from rat plasma. To an aliquot of
500 lL plasma sample, IS solution (200 lL of 5 lg/mL) was
added and mixed for 45 s on a Cyclomixer (Remi
Instruments, Mumbai, India) then doxylamine standard solu-
tion (200 lL of 1–14 lg/mL) was added and mixed for 45 s
on a Cyclomixer. The sample solution was made up to 2 mL
with acetonitrile followed by centrifugation for 10 min at
10,000 rpm on a Remi Centrifuge (Eppendorf, Germany) at
4 C. The supernatant layer was transferred into another tube
and ﬁltered through a 0.45 lm syringe ﬁlter. A 10 lL of the
ﬁltrate was injected onto the HPLC column.
2.8. Validation procedure
2.8.1. Speciﬁcity and selectivity
The speciﬁcity of the method was evaluated by analyzing rat
plasma samples from at least six different lots to investigate
the potential interferences at the LC peak region for enan-
tiomers and IS. The acceptance criterion for the experiment
was that at least four out of six lots should have response less
than ﬁve times the lower limit of quantitation (LLOQ) level
response in the same matrix.
2.8.2. Recovery
The efﬁciency of Doxylamine enantiomers and IS extracted
from rat plasma was determined by comparing the responses
of the analyte extracted from replicating QC samples (n= 6)
with the response of analyte from neat standards at equivalent
concentrations by the protein precipitation process. Recoveries
of Doxylamine enantiomers were determined at QC low and
QC high concentrations that is, 200 and 1000 ng/mL. whereas
the recovery of the IS was determined at a single concentration
of 500 ng/mL
Extraction efficiency ¼ Cex=C0 ð1Þ
where Cex = concentration of doxylamine enantiomer from
spiked plasma sample. C0 = concentration of doxylamine
enantiomer obtained after direct injection.
2.8.3. Calibration curve
The six point calibration curve (100, 200, 600, 800, 1000 and
1400 ng/mL) was constructed by plotting the peak area ratio
of Doxylamine enantiomer: IS against the nominal concentra-
tion of calibration standards in blank rat plasma. Following
the evaluation of different dilution factors, the results were ﬁt-
ted to linear regression analysis. The calibration curve had to
have a correlation coefﬁcient (r) of 0.99 or better. For each
back-calculated standard concentration the acceptance criteria
were ±15% deviation from the actual value except at LLOQ,
which was set at ±20%.
2.8.4. Precision and accuracy
The intra-assay precision and accuracy were estimated
by analyzing six replicates containing doxylamine at four
different QC levels, that is, 100, 200, 600 and 1000 ng/mL.
The inter-assay precision was determined by analyzing the four
levels of QC samples on four different runs. The criteria foracceptability of the data include, accuracy within 85–115%
of the actual values and a precision of within ±15%
relative standard deviation (RSD) except for LLOQ,
where it should be within 80–120% for accuracy and <20%
of RSD.
2.8.5. Stability experiments
Stability tests were conducted to evaluate the stability of
Doxylamine enantiomers in plasma samples under different
conditions. Stock solution stability (6 h) was done by keeping
the original stock solution, spiked stock solution and IS stock
solution at room temperature for 6 h. then processed, analyzed
and compared with the freshly prepared solutions, In-injector
stability (24 h), bench-top stability (12 h), freeze–thaw stability
(three cycles) in which three aliquots of LQC (200 ng/mL) and
HQC (1000 ng/mL) samples were kept in the freezer (20 C)
for about 24 h and then thawed at room temperature. This
cycle is repeated for two more times and the samples were ana-
lyzed after the third cycle. Freezer stability (20± 10 C for
25 days) was tested at LQC (200 ng/ml) and HQC
(1000 ng/mL) levels using three replicates at each level.
Samples were considered stable if assay values were within
the acceptable limits of accuracy (i.e. 85–115% of fresh sam-
ples) and precision (i.e. ±15% RSD).
3. Results
3.1. Optimization of chromatographic conditions
The method was optimized to separate the two enantiomers of
doxylamine succinate. The main target of the chromatographic
method is to get the separation between the closely eluting
enantiomers which have the same physical–chemical proper-
ties. The structure and nature of the chiral stationary phase
(CSP) play a very important role in the resolution of enan-
tiomers. Nowadays most of the racemic drugs are being
resolved by using polysaccharide chiral columns.
Polysaccharide based chiral columns contain amylose or cellu-
lose as a back bone forming a helical structure in the coating.
When compared with amylose, the cellulose helical structure
was coiled loosely which accommodates the enantiomer inter-
action more readily. Cellulose Tris (4-chloro-3-methylphenylc
arbamte)13 is the chlorinated cellulose derivative column which
offers a unique chiral recognition abilities. The separation was
tried on this column using basic buffers (the enantiomeric res-
olution of doxylamine is pH sensitive. And as the drug is a
basic one, the method development was started with the basic
pH buffers. Finally, both the enantiomers of doxylamine were
resolved properly at pH 6.6.) and organic solvents like acetoni-
trile, methanol and isopropanol with different proportions.
The effect of alcoholic modiﬁers on the resolution of enan-
tiomers is depicted in Fig 2. As it is seen the retention increased
in the order acetonitrile < isopropanol < methanol. Hence
acetonitrile has been optimized as an alcoholic modiﬁer. In
order to improve the resolution factor between the enan-
tiomers different organic modiﬁers like tri-ethylamine and
diethylamine were used in the mobile phase. The effect of buf-
fer strength and % organic modiﬁer on the resolution of enan-
tiomers has been studied and represented graphically
(Fig. 3a,b). From this study it is concluded that as the buffer
strength increases the resolution between the enantiomers
Figure 2 Effect of alcoholic modiﬁers on the retention of enantiomers (a) methanol, (b) isopropanol, (c) acetonitrile.
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tion between the enantiomers increases. Hence, from the study
the buffer strength and % organic modiﬁer were optimized to
20 mM and 0.15% respectively. The effect of column oven
temperature on the resolution of doxylamine enantiomers is
represented in Fig. 3c which says that the increase in column
oven temperature increases the solubility of the compound in
the mobile phase, hence better resolution is obtained
between the enantiomers. Thus the mixture of 20 mM
ammonium bicarbonate buffer, acetonitrile and diethylamine(65:35:0.15 v/v/v) as a mobile phase with 1.0 mL/min ﬂow rate
through Cellulose column (250 mm · 4.6 mm, 5 lm) at 40 C
column oven temperature and 220 nm wavelength was success-
ful in separating both the enantiomers and the internal
standard (Table 1).
3.2. Elution order of enantiomers
The elution order of the doxylamine enantiomers, was deter-
mined by injecting the freshly prepared (d)-doxylamine stock
Figure 3 (a) Effect of buffer strength of the capacity factor of ‘l’ enantiomer (k1) and capacity factor of ‘d’ enantiomer (k2), (b) effect of
% diethylamine (DEA) on the capacity factor of ‘l’ enantiomer (k1) and capacity factor of ‘d’ enantiomer (k2), (c) effect of column oven
temperature on the capacity factor of ‘l’ enantiomer (k1) and capacity factor of ‘d’ enantiomer (k2).
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the racemic mixture peaks. It was found that the diastere-
omeric complex formed by the (d)-doxylamine has morebinding afﬁnity toward the stationary phase compared to
(l)-doxylamine. Hence it was conﬁrmed that the (l)-form of
doxylamine elutes earlier than (d)-doxylamine.
Table 1 Chromatography data for enantioseparation of
doxylamine on chiral column.
S.
No.
Chromatographic parameter Formula Values
obtained
1 Capacity factor of ﬁrst eluted
enantiomer (K1)
K1 ¼ t1t0t0 1.62
2 Capacity factor of second eluted
enantiomer (K2)
K2 ¼ t2t0t0 1.82
3 Selectivity factor a ¼ K2K1 1.12
4 Resolution factor Rs ¼ 2ðt2t1Þw1þw2 2.7
5 Theoretical plates
N ¼ 16 trwb
 2 6320
Where t0 = retention time of unretained compound.
t1 = retention time of earlier eluted compound.
t2 = retention time of later eluted compound.
k1 = capacity factor of earlier eluted compound.
k2 = capacity factor of the later eluted compound.
w1 = peak width of earlier eluted compound.
w2 = peak width of later eluted compound.
tr = retention time of peak.
wb = the peak width at a given peak height.
Figure 4 Chromatogra
Figure 5 (a) Chromatograms of blank plasma sample, (
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A full validation according to the USFDA14 was performed
for the estimation of doxylamine enantiomers in rat plasma.
The proposed method was validated with respect to selectivity,
linearity, accuracy, precision, recovery, and stability.
3.3.1. Speciﬁcity and selectivity
Selectivity is the capability of the developed method to differ-
entiate the analyte with the other endogenous components in
the sample. Selectivity is ensured at LLOQ level (Fig. 5).
Aqueous samples of LLOQ were injected six times. Spiked
samples of LLOQ were injected six times along with six injec-
tions of blank plasma sample. All the chromatograms were
analyzed and found that the doxylamine enantiomers and
the internal standard peaks did not interfere with any endoge-
nous components. There was also a good resolution between
the two enantiomer peaks. Sensitivity is deﬁned as the lowest
analyte concentration that can be measured with acceptable
accuracy and precision (i.e., LLOQ) and from the method
the LLOQ was found to be 100 ng/mL.m of (d)-doxylamine.
b) aqueous LLOQ sample, (c) spiked LLOQ sample.
Table 2 Recovery of doxylamine enantiomers (n= 6).
Quality control sample (ng/mL) Mean recovery % (SD)
(l)-doxylamine (d)-doxylamine
LQC (200) 102.2 (2) 103 (7.60)
MQC (600) 96.4 (3) 101.5 (2.7)
HQC (1000) 102.4 (6) 94.5 (8.9)
Table 3 Intra-day and inter-day accuracy and precision data
(n= 6).
Validation parameter (l)-doxylamine (d)-doxylamine
Concentration (ng/mL) Intra-day repeatability CV (%)
LLOQ (100) 7.1 10.5
LQC (200) 5.1 3.3
MQC (600) 4.1 2.0
HQC (1000) 4.5 1.7
Inter-day repeatability CV (%)
LLOQ (100) 6.5 6.6
LQC (200) 4.6 3.1
MQC (600) 6.4 3.7
HQC (1000) 4.2 1.7
Accuracy (%) (SD)
LLOQ (100) 93.4 (6.6) 101.7 (10.7)
LQC (200) 106.9 (5.7) 93.7 (3.1)
MQC (600) 106.4 (4.4) 99.8 (2.0)
HQC (1000) 103 (4.6) 104.4 (1.8)
Linearity range (ng/mL) 100–1400 100–1400
y-Intercept 0.0195 0.0118
Slope 0.3416 0.3269
R2 0.998 0.996
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The efﬁciency of extraction procedure employed was deter-
mined by comparing the peak area of the analyte extracted
from replicate QC samples (n= 6) by a protein precipitation
process with the peak area of analyte from neat standards at
equivalent concentrations. Recoveries of doxylamine succinate
were determined at low (LQC), medium (MQC) and high
(HQC) quality control concentrations i.e., 200, 600 and
1000 ng/mL. Mean recoveries for each enantiomer are men-
tioned in Table 2. It was found that the recoveries were ranged
from 96.4 to 102.4% for (l)-doxylamine and 94.5–103% for
(d)-doxylamine enantiomers.
3.3.3. Calibration curve
The six point calibration curve (100, 200, 600, 800, 1000 and
1400 ng/mL) was constructed by plotting the peak area ratio
of doxylamine succinate: IS (500 ng/mL) against the nominal
concentration of calibration standards in blank rat plasma
(Fig. 6). Excellent linearity with a high correlation coefﬁcient
(0.995–0.996) was observed.
3.3.4. Precision and accuracy
The intra-day and inter-day precision and accuracy were esti-
mated by analyzing six replicates containing doxylamine succi-
nate at the lower limit of quantiﬁcation (LLOQ) and three
different QC levels, that is, 100, 200, 600 and 1000 ng/mL
respectively. The six replicates of each quality control sample
were analyzed on the same day and also on three nonFigure 6 Chromatograms of (a) blank plasma, (b) plasma spiked
doxylamine 100 ng/mL, (d) 200 ng/mL, (e) 600 ng/mL, (f) 800 ng/mL,consecutive days to determine the intra-day and inter-day pre-
cision and the accuracy. The results of accuracy and precision
are summarized in Table 3. The precisions of (l)- and (d)-
doxylamine enantiomers were <7.1 and 10.5%, respectively.
The accuracy, expressed as a percentage of the measured con-
centration to the theoretical concentration was ranged from
93.4 to 106.9% for (l)-enantiomer and 93.7–104.4% for (d)-
doxylamine enantiomer.
3.3.5. Stability experiments
Stability tests were conducted to evaluate the stability of doxy-
lamine enantiomers in plasma samples under different
conditions at low (200 ng/mL) and high (1000 ng/mL)with only IS, (c) plasma spiked with different concentrations of
(g) 1000 ng/mL, (h) 1400 ng/mL.
Table 4 Stability of doxylamine enantiomers in plasma (n= 3).
Concentration added (ng/mL) Concentration found (ng/mL) Accuracy (%) (SD)
(l)-doxylamine (d)-doxylamine (l)-doxylamine (d)-doxylamine
In-injector stability (24 h)
LQC (200) 202.8 197 101.4 (4.0) 98.5 (3.4)
HQC (1000) 977 987 97.7 (4.8) 98.7 (4.7)
Freeze–thaw stability (three cycles)
LQC (200) 191.6 193.6 95.8 (5.6) 96.8 (4.3)
HQC (1000) 1016 1025 101.6 (2.8) 102.5 (2.0)
Freezer stability (25 days)
LQC (200) 190.8 190.2 95.4 (2.4) 95.1 (3.1)
HQC (1000) 976 964 97.6 (1.9) 96.4 (1.9)
Bench top stability (12 h)
LQC (200) 200.8 206 100.4 (3.6) 103 (2.7)
HQC (1000) 987 1018 98.7 (2.3) 101.8 (0.9)
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ity (24 h), bench-top stability (12 h), freeze–thaw stability
(three cycles) and freezer stability (20 ± 10 C for 25 days)
were tested. As shown in Table 4, the results for stability of the
(d)- and (l)-enantiomers were found to be stable in rat plasma.
4. Discussion
The method resolved the (d) and (l) enantiomers of doxy-
lamine in rat plasma. The concentration of organic modiﬁer
and the buffer strength played an important role to achieve
better retention and resolution between the enantiomers. The
selectivity of the enantiomers on the cellulose column was
good and no endogenous peaks from plasma interfered with
the enantiomer peaks. Doxylamine enantiomers were extracted
efﬁciently from rat plasma by a simple protein precipitating
process using acetonitrile as a protein precipitating agent.
The chromatographic parameters like capacity factor (k), sep-
aration factor (a) were found to be better than the reported
methods. The sensitivity of the method was found to be very
low compared with reported methods. The method was devel-
oped in the reverse phase mode in which the results will be
more reproducible compared with the existing normal phase
methods (9, 10). The enantiomers were found to be precise,
accurate to within the runs, and between the runs also found
to be stable in different stability conditions.5. Conclusion
In summary, we have developed and validated a sensitive,
speciﬁc and reproducible UFLC assay to quantitate doxy-
lamine enantiomers in rat plasma. The method involved sam-
ple preparation with adequate recovery by simple one-step
protein precipitation. This method can be further explored
for the quantiﬁcation of doxylamine enantiomers in clinical
drug monitoring and in studying the pharmacokinetics proﬁle.
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